Skip to main content
Premium Trial:

Request an Annual Quote

CDD, St. Jude Alliance Aims to Quicken Rx Development for Resistant Malaria

NEW YORK (GenomeWeb News) — Collaborative Drug Discovery and St. Jude Children's Research Hospital have penned an alliance to speed the development of drugs to treat resistant strains of malaria.
The collaboration is designed to help scientists quickly screen millions of chemicals, based on their structure and their chemical and biological properties, to find those that are most likely to make effective anti-malaria drugs.
It combines the drug-discovery expertise of the St. Jude Department of Chemical Biology and Therapeutics with CDD’s malaria drug data and informatics technology, which “will probably help us reduce the number of potential molecules we'll need to analyze from tens of millions down to hundreds of thousands," Kip Guy, chair of the St. Jude Department of Chemical Biology and Therapeutics, said in a statement.
"Our own screening capability will significantly reduce that to a much smaller number of promising compounds,” he said. “This will be a widely used database. We are already making the data freely available through CDD so that other researchers can use different analytical strategies to identify potential new anti-malarial drugs."
The malaria project is the “first of several” that CDD plans as it aims to “help the research community discover drugs for orphan infectious diseases-disorders.” Future CDD projects are planned in other more commercial areas, such as cancer research and selected gene families, the company said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.